Chat with Filing

Ask questions about this document

Please log in or register to use the chat feature. Please register first.

RNS - dsm-firmenich completes sale of its stake in Feed Enzymes Alliance to Novonesis for €1.5 billion

Company: DSM-Firmenich AG Date: 2025-06-02 Language: English Register to download

Loading document preview...

Document Preview Not Available

The file type (.pdf) cannot be displayed directly here.

Open Original File

Error loading document preview. Please try the 'Open Original File' link.

You're One Click Away From The Full Filing

Instantly access this document—and 2.8M more—for free. Select your preferred method:

Continue with Google Continue with Microsoft Continue with Facebook Continue with Amazon

![](_page_0_Picture_1.jpeg)

**Press Release**

# **dsm-firmenich completes sale of its stake in Feed Enzymes Alliance to Novonesis for €1.5 billion**

Kaiseraugst (Switzerland), Maastricht (Netherlands), June 2, 2025

dsm-firmenich, innovators in nutrition, health, and beauty, today announces the successful completion of the sale of its stake in the Feed Enzymes Alliance to its partner Novonesis, a global leader in biosolutions, for €1.5 billion. The sale agreement was announced on [February 11, 2025.](https://our-company.dsm-firmenich.com/en/our-company/news/press-releases/2025/dsm-firmenich-to-sell-stake-in-feed-enzymes-alliance-to-its-partner-novonesis-for-1-5-billion.html)

dsm-firmenich received approximately €1.4 billion net in cash, after transaction costs.

## **About dsm-firmenich**

As innovators in nutrition, health, and beauty, dsm-firmenich reinvents, manufactures, and combines vital nutrients, flavors, and fragrances for the world's growing population to thrive. With our comprehensive range of solutions, with natural and renewable ingredients and renowned science and technology capabilities, we work to create what is essential for life, desirable for consumers, and more sustainable for the planet. dsm-firmenich is a Swiss company, listed on the Euronext Amsterdam, with operations in almost 60 countries and revenues of more than €12 billion. With a diverse, worldwide team of nearly 30,000 employees, we bring progress to life every day, everywhere, for billions of people. [www.dsm-firmenich.com](http://www.dsm-firmenich.com/)

## **For more information**

**Media relations Investor relations** Robin Roothans Dave Huizing tel. +41 (0)79 280 03 96 tel. +31 (0)88 425 7306

e-mail [media@dsm-firmenich.com](mailto:media@dsm-firmenich.com) e-mail [investors@dsm-firmenich.com](mailto:investors@dsm-firmenich.com)

#### Forward-looking statements

This press release may contain forward-looking statements with respect to dsm-firmenich's future (financial) performance and position. Such statements are based on current expectations, estimates

![](_page_1_Picture_0.jpeg)

and projections of dsm-firmenich and information currently available to the company. dsm-firmenich cautions readers that such statements involve certain risks and uncertainties that are difficult to predict and therefore it should be understood that many factors can cause actual performance and position to differ materially from these statements. dsm-firmenich has no obligation to update the statements contained in this press release, unless required by law. This communication contains information that qualifies as inside information within the meaning of Article 7(1) of the EU Market Abuse Regulation. The English language version of the press release is leading.

Unlock Europe's Largest Financial Database—Free

Get instant access to over 2.8M filings from 8,970 companies across 44 markets. No cost. No hassle. Just results.

Save hours with instant data access
Trusted by leading financial institutions
Free forever—no strings attached

Or sign up with

Google Microsoft

Or log in with

Google Microsoft

This premium feature is designed for professionals. Upgrade your plan to gain immediate access and enhance your research capabilities.

Upgrade Now